Analisis Efektivitas Biaya Antidiabetik Oral Pada Penderita Diabetes Melitus Tipe 2 Rawat Inap Peserta Bpjs Di Rsud Sukoharjo Tahun 2016

Harjanto, Achmad and , Mariska Sri Harlianti, M.Sc., Apt. (2017) Analisis Efektivitas Biaya Antidiabetik Oral Pada Penderita Diabetes Melitus Tipe 2 Rawat Inap Peserta Bpjs Di Rsud Sukoharjo Tahun 2016. Skripsi thesis, Universitas Muhammadiyah Surakarta.

	PDF (Naskah Publikasi) NASKAH PUBLIKASI.pdf Download (1MB)
	PDF (Halaman Depan) Halaman Depan.pdf Download (3MB)
	PDF (Bab I) Bab I.pdf Download (287kB)
	PDF (Bab II) Bab II.pdf Restricted to Repository staff only Download (205kB) | Request a copy
	PDF (Bab III) Bab III.pdf Restricted to Repository staff only Download (196kB) | Request a copy
	PDF (Bab IV) Bab IV.pdf Restricted to Repository staff only Download (7kB) | Request a copy
	PDF (Daftar Pustaka) Daftar Pustaka.pdf Download (88kB)
	PDF (Lampiran) Lampiran.pdf Restricted to Repository staff only Download (1MB) | Request a copy
	PDF (Pernyataan Publikasi Ilmiah) publikasi.pdf Restricted to Repository staff only Download (489kB) | Request a copy

Abstract

Diabetes mellitus is a long-term degenerative diseases that can lead to kidney, eye, nervous system complications and increased cardiovascular risk. That’s make medication diabetes mellitus requiring long treatment therapies and substantial amount of cost. This study aims to know general overview of treatment and cost effectiveness of oral antidiabetic therapy for in-patients with type 2 diabetes mellitus and BPJS members at Sukoharjo Hospital in 2016. This study used observational method. Medical record of in-patients with type 2 diabetes mellitus and members of BPJS at Sukoharjo Hospital 2016 was collected retrospectively. Purposive sampling method was used as sampling technique. There were 32 patients met inclusion criteria. The result shows oral antidiabetic used in Sukoharjo Hospital in 2016 was combination of metformin and glimepiride 31,25%, combination metformin, glimepiride and akarbose 21,87%, metformin 18,75%, metformin and akarbose 15,62%, combination metformin, glibenclamide and akarbose 6,25%, glimepiride and akarbose 3,12%, metformin and glibenclamide 3,12%. The most cost-effective oral antidiabetic according ACER and ICER values was found in class III using combination metformin and glibenclamide with ACER was Rp. 11.203,54 and ICER was Rp. 1.380,56.

Item Type:	Karya ilmiah (Skripsi)
Uncontrolled Keywords:	Diabetes melitus, antidiabetik oral, efektivitas biaya, BPJS, RSUD Sukoharjo.
Subjects:	R Medicine > RS Pharmacy and materia medica R Medicine > RZ Other systems of medicine
Divisions:	Fakultas Farmasi > Farmasi
Depositing User:	ACHMAD HARJANTO
Date Deposited:	05 Aug 2017 05:03
Last Modified:	05 Aug 2017 05:03
URI:	http://eprints.ums.ac.id/id/eprint/54572

Actions (login required)

View Item